Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 630 Boulevard René-Lévesque O, 20th Floor,canada
- Phone
- (514) 825-9035
- in****@****ant.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- giiant.com
- Keywords
- Coordinator jobs.
- HQ
- Montreal, Quebec
Giiant Pharma Inc. Questions
Giiant Pharma Inc.'s helpline number is (514) 825-9035
Giiant Pharma Inc.'s website is giiant.com
Giiant Pharma Inc.'s LinkedIn profile is https://ca.linkedin.com/company/giiantpharma
Giiant Pharma Inc. has
3 employees.
View email and phone details for 3
employees at Giiant Pharma Inc..
Giiant Pharma Inc.'s industry is
Biotechnology Research
Giiant Pharma Inc.'s top competitors are
Congruence Therapeutics,
Thryv Therapeutics Inc.,
Cura Therapeutics Inc.,
Milestone Pharmaceuticals, Inc.,
Laurent Pharmaceuticals,
Inversago Pharma,
Nomic Bio,
Pharmascience,
Palisade Bio,
Modulari-T Bio.
Giiant Pharma Inc.'s support email address is info@giiant.com
Giiant Pharma Inc.'s categories are Biotechnology Research
Giiant Pharma Inc.'s founding year is 2014
